T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2022-10-01
|
| Reeks: | HemaSphere |
| Online toegang: | http://journals.lww.com/10.1097/01.HS9.0000890964.54059.2c |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
